- Previous Close
49.35 - Open
49.65 - Bid 48.50 x --
- Ask 48.85 x --
- Day's Range
48.50 - 49.65 - 52 Week Range
48.50 - 75.20 - Volume
22,150 - Avg. Volume
24,746 - Market Cap (intraday)
2.298B - Beta (5Y Monthly) 0.36
- PE Ratio (TTM)
35.14 - EPS (TTM)
1.38 - Earnings Date --
- Forward Dividend & Yield 1.30 (2.23%)
- Ex-Dividend Date Jul 26, 2024
- 1y Target Est
--
Luo Lih-Fen Holding Co., Ltd. researches and develops, manufactures, and sells cosmetics and medical devices in Taiwan and Mainland China. Its products portfolio includes washing, hydration, essence, and cream masks, as well as facial kits, eye kits, health preservation kits, oral health preservation food, and beauty care instruments. The company also offers skin care products, beauty and skin care consulting services, and medical cosmetology services. In addition, it operates and manages healthcare and biocare beauty salons, as well as offers related personnel training services. Additionally, the company engages in general investment and real leasing activities. Further, it sells raw material, semi-finished products, and packaging materials. The company offers its products under the GLINGLUO, SUNLILY, DRAISE, QIECOME, MallSkin, Ubeauty, and EasyBio brand names. Luo Lih-Fen Holding Co., Ltd. was founded in 1986 and is headquartered in Grand Cayman, the Cayman Islands.
luolifen.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 6666.TW
View MorePerformance Overview: 6666.TW
Trailing total returns as of 1/9/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6666.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6666.TW
View MoreValuation Measures
Market Cap
2.34B
Enterprise Value
1.44B
Trailing P/E
35.76
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.55
Price/Book (mrq)
1.37
Enterprise Value/Revenue
1.57
Enterprise Value/EBITDA
8.51
Financial Highlights
Profitability and Income Statement
Profit Margin
7.36%
Return on Assets (ttm)
2.76%
Return on Equity (ttm)
5.28%
Revenue (ttm)
1.06B
Net Income Avi to Common (ttm)
78.31M
Diluted EPS (ttm)
1.38
Balance Sheet and Cash Flow
Total Cash (mrq)
945.9M
Total Debt/Equity (mrq)
5.28%
Levered Free Cash Flow (ttm)
195.05M